Disseminating Effective Sexual Health Programs in Schools Using iCHAMPSS

NCT07679620 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2026-07-01

No results posted yet for this study

Summary

The purpose of this study is to assess the efficacy of iCHAMPSS 2.0 in impacting Reach Effectiveness Adoption Implementation Maintenance (RE-AIM) implementation outcomes, with implementation of a sexual health evidence-based program (EBP) assess iCHAMPSS 2.0's efficacy in impacting determinants of sexual health EBP implementation and to conduct a process evaluation to monitor iCHAMPSS 2.0 implementation, reach, dosage, and barriers and facilitators to implementing iCHAMPSS 2.0 during the study.

Conditions

  • Sexual Health Education

Interventions

BEHAVIORAL

iCHAMPSS 2.0

iCHAMPSS 2.0 is designed for Program Champions, critical to EBP use, such as district and school administrators, SHAC members (which include parents), and health and physical education teachers, who are highly motivated to promote sexual health education. iCHAMPSS 2.0 has four features: 1. the CHAMPSS Model tutorial, which familiarizes Champions with the iCHAMPSS 2.0 system 2. a Staging Tool, which helps Champions understand their school's level of readiness to adopt, implement, and maintain a sexual health EBP, and can tailor their experience 3. a tools library, which includes a suite of over 60 decision support tools 4. an interactive linkage system, which is an online platform to help Champions connect with others and to receive technical assistance (TA)

Sponsors & Collaborators

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH
  • The University of Texas Health Science Center, Houston

    lead OTHER

Principal Investigators

  • Belinda Hernandez, PhD, MPH · The University of Texas Health Science Center, Houston

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-04-02
Primary Completion
2028-04-01
Completion
2028-04-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07679620 on ClinicalTrials.gov